A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma
Completed
- Conditions
- Psychological DistressInsomniaSomatic Symptoms
- Registration Number
- NCT05620420
- Lead Sponsor
- RenJi Hospital
- Brief Summary
Multiple myeloma patients with normal ability of communication and understanding will be enrolled. DT, GAD-7, PHQ-15 and PSQI scales are designed to assess the mental health status of the patients. Demographic and disease data of patients will be collected as well. The main aim is to explore the factors affecting the mental health of myeloma patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 501
Inclusion Criteria
- Patients with symptomatic multiple myeloma were diagnosed according to the criteria of Chinese multiple myeloma diagnosis and treatment guidelines (revised in 2022).
- Age ≥18 years, with junior high school education or above. Patients have normal ability of communication and understanding.
- Informed consent has been signed.
Exclusion Criteria
- Who has kinship with other enrolled patients.
- Life expectancy of< 6 months.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method morbidity of psychological distress in patients with multiple myeloma. Baseline (the time when the patient is enrolled to the study) The total score of DT scale ≥4 points is defined as obviously psychological distress.
- Secondary Outcome Measures
Name Time Method morbidity of anxiety in patients with multiple myeloma. Baseline (the time when the patient is enrolled to the study) GAD-7 scale is applied to assess the anxiety of the patient
morbidity of insomnia in patients with multiple myeloma. Baseline (the time when the patient is enrolled to the study) PSQI scale is applied to assess the insomnia of the patient
Trial Locations
- Locations (1)
shanghai Jiaotong University School of Medicine, Renji Hospital
🇨🇳Shanghai, Shanghai, China